Generating Inhibitors of P-Glycoprotein: Where to, Now?
The prominent role for the drug efflux pump ABCB1 (P-glycoprotein) in mediating resistance to chemotherapy was first suggested in 1976 and sparked an incredible drive to restore the efficacy of anticancer drugs. Achieving this goal seemed inevitable in 1982 when a series of calcium channel blockers were demonstrated to restore the efficacy of chemotherapy agents. A large number of other compounds have since been demonstrated to restore chemotherapeutic sensitivity in cancer cells or tissues....[Show more]
|Collections||ANU Research Publications|
|Source:||Methods in Molecular Biology|
|01_Crowley_Generating_Inhibitors_of_2010.pdf||1.14 MB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.